Labwire, Inc.
Other OTCTotal Valuation
Labwire, Inc. carries a market capitalization of 59,138.00, placing it among publicly traded companies globally. Its enterprise value stands at 959,834.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 59,138.00 |
| Enterprise Value | 959,834.00 |
Share Statistics
Labwire, Inc. currently has 142.70M shares outstanding.
| Shares Outstanding | 142.70M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
On an enterprise value basis, Labwire, Inc. trades at an EV/EBITDA multiple of 13.30 and an EV/FCF ratio of 2.34. The EV/Sales ratio of 0.21 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 195.72 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.21 |
| EV / EBITDA | 13.30 |
| EV / EBIT | 195.72 |
| EV / FCF | 2.34 |
Financial Position
Labwire, Inc. maintains a current ratio of 0.67, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2,265.64, indicating conservative leverage, while an interest coverage ratio of 0.58 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.67 |
| Quick Ratio | 0.52 |
| Debt / Equity | -2,265.64 |
| Debt / EBITDA | 14.19 |
| Interest Coverage | 0.58 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -9.88 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 106.37 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Labwire, Inc. has paid 46,625.00 in income taxes, reflecting an effective tax rate of 79.04.
| Income Tax | 46,625.00 |
| Effective Tax Rate | 79.04 |
Stock Price Statistics
Labwire, Inc.'s stock has gained approximately 300.00001% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 300.00001% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Labwire, Inc. generated 4.47M in revenue and converted that into -166,205.00 in net income, yielding earnings per share of 0.00. EBITDA reached 72,163.00, while operating income came in at 4,904.00.
| Revenue | 4.47M |
| Gross Profit | 1.95M |
| Operating Income | 4,904.00 |
| Pretax Income | -119,580.00 |
| Net Income | -166,205.00 |
| EBITDA | 72,163.00 |
| EBIT | 4,904.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Labwire, Inc. holds 64,007.00 in cash and equivalents against 1.02M in total debt, resulting in a net debt position of 959,834.00. Total book value stands at -715,864.00, with working capital of -512,059.00 providing operational flexibility.
| Cash & Cash Equivalents | 64,007.00 |
| Total Debt | 1.02M |
| Net Debt | 959,834.00 |
| Equity (Book Value) | -715,864.00 |
| Book Value Per Share | -0.01 |
| Working Capital | -512,059.00 |
Cash Flow
Labwire, Inc. produced 77,496.00 in operating cash flow over the past twelve months. After subtracting -159,870.00 in capital expenditures, free cash flow totaled -82,374.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 77,496.00 |
| Capital Expenditures | -159,870.00 |
| Free Cash Flow | -82,374.00 |
| FCF Per Share | 0.00 |
Margins
Labwire, Inc. operates with a gross margin of 43.76, reflecting its pricing power and cost economics. The operating margin of 0.11 and net profit margin of -3.72 provide insight into operational efficiency.
| Gross Margin | 43.76 |
| Operating Margin | 0.11 |
| Pretax Margin | -2.68 |
| Profit Margin | -3.72 |
| EBITDA Margin | 1.62 |
Scores
Labwire, Inc. posts an Altman Z-Score of 2.00, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.00 |